Sernova (TSE:SVA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sernova Corp., a biotech company advancing cell therapies for chronic diseases, has announced the appointment of biotech veteran David Paterson Ph.D. to its Board of Directors. Paterson’s extensive experience in corporate development and his biopharma industry knowledge are expected to bolster Sernova’s growth and its innovative Cell Pouch System technology, particularly in the type 1 diabetes sector.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
